![External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging - Soeterik - External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging - Soeterik -](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/9d5ee1fb-33f1-48da-924c-36a2e1471e12/bju15376-fig-0002-m.jpg)
External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging - Soeterik -
![Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2017.47/MediaObjects/41416_2017_Article_BFbjc201747_Fig1_HTML.jpg)
Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and
![Cancers | Free Full-Text | Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Cancers | Free Full-Text | Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390](https://www.mdpi.com/cancers/cancers-12-00808/article_deploy/html/images/cancers-12-00808-g002.png)
Cancers | Free Full-Text | Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390
![PDF) Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients PDF) Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients](https://www.researchgate.net/publication/340345301/figure/tbl1/AS:876560693338113@1585999763681/Patient-characteristics-based-on-MSKCC-risk-groups-and-details-on-MSKCC-risk-factors_Q320.jpg)
PDF) Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients
![The Memorial Sloan Kettering Cancer Center Nomogram is More Accurate than the 2009 FIGO Staging System in the Prediction of Overall Survival in a German Endometrial Cancer Patient Cohort | SpringerLink The Memorial Sloan Kettering Cancer Center Nomogram is More Accurate than the 2009 FIGO Staging System in the Prediction of Overall Survival in a German Endometrial Cancer Patient Cohort | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1245%2Fs10434-018-6756-3/MediaObjects/10434_2018_6756_Fig2_HTML.png)
The Memorial Sloan Kettering Cancer Center Nomogram is More Accurate than the 2009 FIGO Staging System in the Prediction of Overall Survival in a German Endometrial Cancer Patient Cohort | SpringerLink
![Updated Clinical Calculator Guides Treatment Plan for Rectal Cancer | Memorial Sloan Kettering Cancer Center Updated Clinical Calculator Guides Treatment Plan for Rectal Cancer | Memorial Sloan Kettering Cancer Center](https://www.mskcc.org/sites/default/files/styles/large/public/node/260526/3x2/weiser_clinic_180831_148_1200x800.jpg)
Updated Clinical Calculator Guides Treatment Plan for Rectal Cancer | Memorial Sloan Kettering Cancer Center
![A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial](https://ars.els-cdn.com/content/image/1-s2.0-S2452109420303109-gr2.jpg)
A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial
![Memorial Sloan-Kettering Cancer Center: Two Decades of Experience with Ductal Carcinoma In Situ of the Breast – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free Memorial Sloan-Kettering Cancer Center: Two Decades of Experience with Ductal Carcinoma In Situ of the Breast – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free](https://cyberleninka.org/viewer_images/989186/f/1.png)
Memorial Sloan-Kettering Cancer Center: Two Decades of Experience with Ductal Carcinoma In Situ of the Breast – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free
![Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram | Journal of Clinical Pathology Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram | Journal of Clinical Pathology](https://jcp.bmj.com/content/jclinpath/67/2/112/F3.large.jpg)
Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram | Journal of Clinical Pathology
Does Albumin Level Change the Strength of the Memorial Sloan Kettering Cancer Center Nomogram Used to Predict 5-year Survival in
![Edison Energy Serves as Technical Consultant for MSKCC's Radiation Oncology Cx Project | Edison Energy Edison Energy Serves as Technical Consultant for MSKCC's Radiation Oncology Cx Project | Edison Energy](https://uploads.edisonenergy.com/2017/12/EES_CaseStudy_MSKCC_RO_chart.png)
Edison Energy Serves as Technical Consultant for MSKCC's Radiation Oncology Cx Project | Edison Energy
![Memorial Sloan Kettering executives' financial ties to industry part of culture problem, report finds | Fierce Healthcare Memorial Sloan Kettering executives' financial ties to industry part of culture problem, report finds | Fierce Healthcare](https://qtxasset.com/quartz/qcloud5/media/image/fiercehealthcare/1554472256/Memorial-Sloan-Kettering-Cancer-Center.jpg?VersionId=3SDyrG4pfpld4LlUNGtCy91NpkWYj1KC)
Memorial Sloan Kettering executives' financial ties to industry part of culture problem, report finds | Fierce Healthcare
![Evaluation of MSKCC Preprostatectomy nomogram in men who undergo MRI-targeted prostate biopsy prior to radical prostatectomy - ScienceDirect Evaluation of MSKCC Preprostatectomy nomogram in men who undergo MRI-targeted prostate biopsy prior to radical prostatectomy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1078143919303242-gr1.jpg)